dextroamphetamine has been researched along with ropinirole in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Fowler, E; Maderal, A; Yosipovitch, G | 1 |
| Barrus, MM; Grottick, AJ; Hobson, S; Hrelja, K; Hynes, TJ; Ma, L; Russell, B; Tremblay, M; Winstanley, CA; Wong, C | 1 |
1 review(s) available for dextroamphetamine and ropinirole
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 other study(ies) available for dextroamphetamine and ropinirole
| Article | Year |
|---|---|
Treatment-induced Delusions of Infestation Associated with Increased Brain Dopamine Levels.
Topics: Aged; Attention Deficit Disorder with Hyperactivity; Brain; Deep Brain Stimulation; Delusional Parasitosis; Dextroamphetamine; Dopamine; Dopamine Agonists; Dopamine Uptake Inhibitors; Female; Humans; Indoles; Male; Middle Aged; Modafinil; Parkinson Disease; Restless Legs Syndrome; Scabies; Wakefulness-Promoting Agents | 2019 |
GPR52 agonists attenuate ropinirole-induced preference for uncertain outcomes.
Topics: Animals; Dextroamphetamine; Dopamine; Dopamine Agonists; Indoles; Male; Rats; Rats, Long-Evans; Receptors, Dopamine D2; Receptors, G-Protein-Coupled; Uncertainty | 2021 |